Current pharmacotherapy for cholestatic liver disease
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.2012.736491
Reference104 articles.
1. The epidemiology of primary biliary cirrhosis
2. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years
3. Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
4. Ursodeoxycholic acid - adverse effects and drug interactions
5. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide;Gut Microbes;2024-09-12
2. The effect of intrahepatic cholestasis of pregnancy and ursodeoxycholic acid treatment on Doppler parameters of fetal and maternal circulation;Ginekologia Polska;2024-07-26
3. UDCA and INT-777 suppress cardiac fibrosis triggered by IL-11 through involvement of TGR5;2022-05-16
4. Gebeligin Intrahepatik Kolestazinda Ursodeoksikolik Asit Tedavisinin Kasinti ve Alanin Amino Transferaz Duzeyine Etkisi;Gazi Medical Journal;2021-04-01
5. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice;Journal of Ethnopharmacology;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3